Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2: Development of Testing Strategies

NCT01112956 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention as lead sponsor.

NCT NCT01112956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01112956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2: Development of Testing Strategies
Lead sponsor
Centers for Disease Control and Prevention
Phase
Observational
Overall status
Completed
Start date
July 31, 2009
Completion date
February 28, 2011
Enrollment
2,500 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

genital herpes